JU Logo Entwürfe v2 07-15

Dr. Sven Hobbie  has been a principal scientist in the development of Juvabis’ proprietary technology platform. Sven holds a PhD of the ETH Zurich and has more than 15 years of hands-on research experience in microbiology and anti-invective drug discovery, with positions held at the Michigan State University, Universität Konstanz, Universität Zürich, the Massachusetts Institute of Technology, and Visterra Inc. Sven’s track record in applied and translational sciences includes both biologics and small molecule therapeutics and is reflected in various research publications, invention disclosures, patents, an MIT Innovation Grant, a PhD award, and an invitation to join the Duke-NUS Medical School as Adjunct Assistant Professor. Sven has contributed to establishing an MIT research institute in Singapore and successfully spinning out the antiviral drug discovery company Visterra Singapore.

Disclaimer     Terms of Use     Privacy Policy                                                                                                             Site Map          Imprint